Mutations in the gene encoding parkin cause an autosomal recessive juvenile-onset form of Parkinson's disease. Parkin functions as a RING-type E3 ubiquitin-ligase, coordinating the transfer of ubiquitin to substrate proteins and thereby targeting them for degradation by the proteasome. We now report that the extreme C terminus of parkin, which is selectively truncated by a Parkinson's disease-causing mutation, functions as a class II PDZ-binding motif that binds CASK, the mammalian homolog of Caenorhabditis elegans Lin-2, but not other PDZ proteins in brain extracts. Importantly, parkin co-localizes with CASK at synapses in cultured cortical neurons as well as in postsynaptic densities and lipid rafts in brain. Further, parkin associates not only with CASK but also with other postsynaptic proteins in the N-methyl D-aspartate (NMDA) receptor-signaling complex, in rat brain in vivo. Finally, despite exhibiting E2-dependent ubiquitin ligase activity, rat brain parkin does not ubiquitinate CASK, suggesting that CASK may function in targeting or scaffolding parkin within the postsynaptic complex rather than as a direct substrate for parkin-mediated ubiquitination. These data implicate for the first time a PDZ-mediated interaction between parkin and CASK in neurodegeneration and possibly in ubiquitination of proteins involved in synaptic transmission and plasticity.Parkinson's disease (PD) 1 involves the selective degeneration of midbrain dopamine neurons, resulting in motor abnormalities and progressive disability. Recently, three genes responsible for inherited forms of PD have been identified. Mutations in the genes encoding ␣-synuclein and ubiquitin C-terminal hydrolase L1 (UCH-L1) each cause rare autosomal dominant forms of PD (1, 2). In contrast, mutations in the gene encoding parkin cause an autosomal recessive, juvenile-onset form of PD and account for more cases of PD than all other familial causes combined (3, 4). Further, Lewy bodies, the cytoplasmic inclusions that constitute the pathological hallmark of the disease, contain ␣-synuclein, UCH-L1 and parkin deposits even in sporadic cases, suggesting a broader role for these three genes in PD (2, 5, 6). Interestingly however, Lewy bodies do not occur in the brains of patients with familial PD caused by parkin mutations, implicating parkin in the biogenesis of these inclusions (3).Another major component of Lewy bodies is ubiquitin (Ub), a small protein that can be covalently attached to other proteins (7). Conjugation of Ub onto proteins requires the concerted activity of three enzymes, an E1 Ub-activating enzyme, an E2 Ub-conjugating enzyme, and an E3 Ub-ligase. Ubiquitinated proteins are then targeted for degradation by the 26 S proteasome. The ubiquitin proteasome pathway (UPP) is one of the main pathways for protein degradation and has been implicated in a number of important cellular regulatory processes (8). There is considerable evidence that parkin also functions in the UPP. Indeed, the N terminus of parkin shares homology with ubiquitin (Ub-like dom...